Merck (MRK) announced it’s buying the Cubist Pharmaceuticals Inc. (NASDAQ:CBST) for $102 per share. Cubist Pharmaceuticals Inc. does advanced antibiotic research and is noted for its research on superbugs — diseases that have developed immunity to antibiotic treatment. Cubist Pharmaceuticals Inc. (NASDAQ:CBST) belongs to Healthcare sector. Its net profit margin is 5.60% and weekly performance is 0.94%. On last trading day company shares ended up $96.73. Cubist Pharmaceuticals Inc. (NASDAQ:CBST) distance from 50-day simple moving average (SMA50) is 31.30%.

BioCryst Pharma (NASDAQ:BCRX) announced the dosing of the first subject in a randomized, placebo-controlled Phase 1 clinical trial to evaluate intramuscular (I.M.) administration of BCX4430 in healthy volunteers. BCX4430 is being developed as a potential treatment for hemorrhagic fever viruses, including Ebola virus and Marburg virus disease. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares moved up 1.39% in last trading session and ended the day at $10.23. BCRX return on assets is -41.80%. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) quarterly performance is -9.47%.

Riverbed Technology Inc. (NASDAQ:RVBD), under pressure all year from activist investor Elliott Management Corp., agreed to be acquired for about $3.6 billion by private-equity firm Thoma Bravo and Canadian pension group Teachers’ Private Capital. Riverbed Technology, Inc. (NASDAQ:RVBD) belongs to Technology sector. Its net profit margin is 2.80% and weekly performance is 5.54%. On last trading day company shares ended up $20.28. Riverbed Technology, Inc. (NASDAQ:RVBD) distance from 50-day simple moving average (SMA50) is 6.78%.

On December 12, eHealth, Inc. (NASDAQ: EHTH), released new educational resources to help consumers navigate their health insurance choices under the Affordable are Act (ACA) during the current nationwide open enrollment period. eHealth, Inc. (NASDAQ:EHTH) ended the last trading day at $26.30. Company weekly volatility is calculated as 3.41% and price to cash ratio as 8.07. eHealth, Inc. (NASDAQ:EHTH) showed a weekly performance of -2.30%.

On Dec 04, IDEX Corporation (NYSE:IEX) announced that its Board of Directors has approved a regular quarterly cash dividend of $0.28 per common share. The next dividend will be paid January 31, 2015 to shareholders of record as of January 15, 2015. This dividend represents the company’s 81st consecutive regular quarterly cash dividend payment. IDEX Corporation (NYSE:IEX) shares moved up 0.51% in last trading session and ended the day at $73.62. IEX Gross Margin is 44.20% and its return on assets is 9.70%. IDEX Corporation (NYSE:IEX) quarterly performance is -1.76%.